Gabriel Leung, Director at NovoCure Ltd (NVCR), sold 20,000 shares at $90.00 ($1.8M) on 2019-11-20, disclosed to the SEC on 2019-11-22.
Open-market sale of $1.8M NVCR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NVCR | SELL | 2024-06-06 | $23K | — | Filing → |
| NVCR | SELL | 2021-08-06 | $153K | — | Filing → |
| NVCR | SELL | 2021-07-08 | $184K | — | Filing → |